Last edition
News about "Dewpoint Therapeutics Inc"
Dewpoint Therapeutics Inc advances MYC small molecule toward oncology development manufacturing
Dewpoint Therapeutics Inc., a biotechnology company developing condensate-modulating medicines, has selected a development candidate for its MYC oncology programme, marking a key step toward advancing a first-in-class small molecule designed to regulate MYC-driven cancer biology.
Dewpoint Therapeutics Inc | 15/02/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members